Symbols / NVOS $0.00 +0.00% Novo Integrated Sciences, Inc.

Healthcare • Medical Care Facilities • United States • PNK
NVOS Chart
About

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training services through clinics. It also provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services through long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology platforms, such as Novo Connect, telemedicine/telehealth, and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Care Facilities Market Cap 61.16K
Enterprise Value 4.92M Income -16.17M Sales 13.29M
Book/sh 0.78 Cash/sh 0.04 Dividend Yield —
Payout 0.00% Employees 115 IPO —
P/E — Forward P/E — PEG —
P/S 0.00 P/B 0.00 P/C —
EV/EBITDA -0.81 EV/Sales 0.37 Quick Ratio 0.19
Current Ratio 0.37 Debt/Eq 40.92 LT Debt/Eq —
EPS (ttm) -1.33 EPS next Y — EPS Growth —
Revenue Growth -6.70% Earnings — ROA -15.35%
ROE -82.47% ROIC — Gross Margin 43.20%
Oper. Margin -30.39% Profit Margin -121.61% Shs Outstand 19.73M
Shs Float 18.43M Short Float 1.45% Short Ratio 1.13
Short Interest — 52W High 0.06 52W Low 0.00
Beta 1.10 Avg Volume 3.51K Volume 1.51K
Target Price — Recom None Prev Close $0.00
Price $0.00 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$4.40
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-08-31 2022-08-31 2021-08-31
Total Revenue
12.57
+7.11%
11.74
+26.14%
9.31
Operating Revenue
12.57
+7.11%
11.74
+26.14%
9.31
Cost Of Revenue
7.62
+9.81%
6.94
+26.57%
5.48
Reconciled Cost Of Revenue
7.62
+9.81%
6.94
+26.57%
5.48
Gross Profit
4.95
+3.20%
4.80
+25.54%
3.82
Operating Expense
13.51
-6.11%
14.39
+77.66%
8.10
Selling General And Administration
13.51
-6.11%
14.39
+77.66%
8.10
Selling And Marketing Expense
0.02
-26.82%
0.02
+175.11%
0.01
General And Administrative Expense
13.49
-6.08%
14.36
+77.57%
8.09
Other Gand A
13.49
-6.08%
14.36
+77.57%
8.09
Total Expenses
21.13
-0.93%
21.32
+57.03%
13.58
Operating Income
-8.55
+10.78%
-9.59
-124.28%
-4.27
Total Operating Income As Reported
-8.55
+65.82%
-25.03
-472.23%
-4.37
EBITDA
-5.85
+73.98%
-22.48
-770.71%
-2.58
Normalized EBITDA
-5.63
+11.94%
-6.40
-157.72%
-2.48
Reconciled Depreciation
2.30
-23.73%
3.02
+75.12%
1.72
EBIT
-8.15
+68.03%
-25.50
-492.19%
-4.31
Total Unusual Items
-0.22
+98.66%
-16.08
-16087.27%
-0.10
Total Unusual Items Excluding Goodwill
-0.22
+98.66%
-16.08
-16087.27%
-0.10
Special Income Charges
0.00
+100.00%
-15.44
-15441.44%
-0.10
Impairment Of Capital Assets
0.00
-100.00%
1.36
+1265.91%
0.10
Write Off
0.00
-100.00%
14.08
+14075.53%
0.10
Net Income
-13.21
+59.77%
-32.85
-636.18%
-4.46
Pretax Income
-13.27
+59.87%
-33.07
-639.61%
-4.47
Net Non Operating Interest Income Expense
-5.11
+30.96%
-7.40
-6101.31%
-0.12
Interest Expense Non Operating
5.12
-32.38%
7.57
+4486.73%
0.17
Net Interest Income
-5.11
+30.96%
-7.40
-6101.31%
-0.12
Interest Expense
5.12
-32.38%
7.57
+4486.73%
0.17
Interest Income Non Operating
0.01
-94.66%
0.17
+270.10%
0.05
Interest Income
0.01
-94.66%
0.17
+270.10%
0.05
Other Income Expense
0.39
+102.44%
-16.08
-20664.38%
-0.08
Other Non Operating Income Expenses
0.61
—
0.02
Gain On Sale Of Security
-0.22
+66.46%
-0.64
—
Tax Provision
0.00
+100.00%
-0.02
0.00
Tax Rate For Calcs
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-13.27
+59.84%
-33.05
-639.11%
-4.47
Net Income From Continuing Operation Net Minority Interest
-13.21
+59.77%
-32.85
-636.18%
-4.46
Net Income From Continuing And Discontinued Operation
-13.21
+59.77%
-32.85
-636.18%
-4.46
Net Income Continuous Operations
-13.27
+59.84%
-33.05
-639.11%
-4.47
Minority Interests
0.05
-71.99%
0.20
+2129.89%
0.01
Normalized Income
-13.00
+22.47%
-16.77
-284.32%
-4.36
Net Income Common Stockholders
-13.21
+59.77%
-32.85
-636.18%
-4.46
Diluted EPS
-1.30
+88.50%
-11.30
-527.78%
-1.80
Basic EPS
-1.30
+88.50%
-11.30
-527.78%
-1.80
Basic Average Shares
10.17
+249.06%
2.91
+17.55%
2.48
Diluted Average Shares
10.17
+249.06%
2.91
+17.55%
2.48
Diluted NI Availto Com Stockholders
-13.21
+59.77%
-32.85
-636.18%
-4.46
Line Item Trend 2023-08-31
Total Assets
35.56
Current Assets
4.39
Cash Cash Equivalents And Short Term Investments
0.42
Cash And Cash Equivalents
0.42
Receivables
1.47
Accounts Receivable
2.22
Receivables Adjustments Allowances
-0.86
Other Receivables
0.11
Inventory
1.11
Raw Materials
0.39
Work In Process
0.08
Finished Goods
0.64
Prepaid Assets
1.05
Other Current Assets
0.35
Total Non Current Assets
31.17
Net PPE
7.37
Gross PPE
8.63
Accumulated Depreciation
-1.25
Properties
0.00
Land And Improvements
0.44
Buildings And Improvements
3.33
Machinery Furniture Equipment
0.12
Other Properties
3.90
Leases
0.84
Goodwill And Other Intangible Assets
23.80
Goodwill
7.58
Other Intangible Assets
16.22
Non Current Accounts Receivable
—
Total Liabilities Net Minority Interest
11.06
Current Liabilities
7.90
Payables And Accrued Expenses
5.09
Payables
3.51
Accounts Payable
3.51
Current Accrued Expenses
1.58
Current Debt And Capital Lease Obligation
2.71
Current Debt
2.29
Other Current Borrowings
2.29
Current Capital Lease Obligation
0.43
Current Deferred Liabilities
0.04
Current Deferred Revenue
0.04
Other Current Liabilities
0.06
Total Non Current Liabilities Net Minority Interest
3.16
Long Term Debt And Capital Lease Obligation
1.76
Long Term Debt
0.07
Long Term Capital Lease Obligation
1.69
Non Current Deferred Liabilities
1.40
Non Current Deferred Taxes Liabilities
1.40
Stockholders Equity
24.82
Common Stock Equity
24.82
Capital Stock
0.02
Common Stock
0.02
Preferred Stock
0.00
Share Issued
16.81
Ordinary Shares Number
16.81
Treasury Shares Number
0.00
Additional Paid In Capital
90.97
Retained Earnings
-67.03
Gains Losses Not Affecting Retained Earnings
-0.36
Minority Interest
-0.32
Other Equity Adjustments
-0.36
Total Equity Gross Minority Interest
24.50
Total Capitalization
24.88
Working Capital
-3.52
Invested Capital
27.17
Total Debt
4.47
Net Debt
1.93
Capital Lease Obligations
2.12
Net Tangible Assets
1.01
Tangible Book Value
1.01
Dueto Related Parties Current
—
Interest Payable
0.38
Inventories Adjustments Allowances
0.00
Other Equity Interest
1.22
Line Item Trend 2023-08-31 2022-08-31 2021-08-31
Operating Cash Flow
-2.24
+61.88%
-5.88
-474.17%
-1.02
Cash Flow From Continuing Operating Activities
-2.24
+61.88%
-5.88
-474.17%
-1.02
Net Income From Continuing Operations
-13.27
+59.84%
-33.05
-639.11%
-4.47
Depreciation Amortization Depletion
2.30
-23.73%
3.02
+75.12%
1.72
Depreciation And Amortization
2.30
-23.73%
3.02
+75.12%
1.72
Other Non Cash Items
7.66
-6.06%
8.16
+437.25%
1.52
Stock Based Compensation
0.39
-9.69%
0.43
+174.41%
0.16
Asset Impairment Charge
0.00
-100.00%
15.74
+15743.07%
0.10
Operating Gains Losses
0.22
-66.46%
0.64
+380.29%
0.13
Gain Loss On Investment Securities
—
0.43
+174.41%
0.16
Net Foreign Currency Exchange Gain Loss
0.22
-66.46%
0.64
0.00
Change In Working Capital
0.46
+155.97%
-0.82
-2728.53%
-0.03
Change In Receivables
-0.60
-230.67%
0.46
-58.60%
1.10
Changes In Account Receivables
-0.60
-230.67%
0.46
-58.60%
1.10
Change In Inventory
-0.26
+51.50%
-0.53
-256.80%
-0.15
Change In Prepaid Assets
0.21
+156.91%
-0.37
-755.78%
-0.04
Change In Payables And Accrued Expense
1.87
+340.82%
0.42
+230.96%
-0.32
Change In Accrued Expense
0.10
-31.81%
0.14
+150.39%
-0.28
Change In Payable
1.77
+525.13%
0.28
+726.24%
-0.05
Change In Account Payable
1.77
+525.13%
0.28
+726.24%
-0.05
Change In Other Current Liabilities
-0.76
+5.40%
-0.81
-30.35%
-0.62
Investing Cash Flow
-0.05
-130.11%
0.16
-94.55%
3.00
Cash Flow From Continuing Investing Activities
-0.05
-130.11%
0.16
-94.55%
3.00
Net PPE Purchase And Sale
-0.05
+74.12%
-0.19
+25.70%
-0.26
Purchase Of PPE
-0.05
+74.12%
-0.19
+25.70%
-0.26
Capital Expenditure
-0.05
+74.12%
-0.19
+25.70%
-0.26
Net Business Purchase And Sale
0.00
-100.00%
0.06
-98.46%
3.73
Purchase Of Business
—
0.00
+100.00%
-0.01
Net Other Investing Changes
—
0.30
+162.60%
-0.47
Financing Cash Flow
0.76
+278.84%
-0.43
-109.89%
4.32
Cash Flow From Continuing Financing Activities
0.76
+278.84%
-0.43
-109.89%
4.32
Net Issuance Payments Of Debt
-1.57
-254.04%
-0.44
+84.02%
-2.78
Issuance Of Debt
1.29
-91.58%
15.27
0.00
Repayment Of Debt
-3.08
+80.40%
-15.71
-465.98%
-2.78
Long Term Debt Payments
-0.05
+99.57%
-10.61
-282.13%
-2.78
Net Long Term Debt Issuance
0.18
+101.67%
-10.61
-282.13%
-2.78
Short Term Debt Issuance
1.29
-91.58%
15.27
0.00
Short Term Debt Payments
-3.03
+40.56%
-5.10
0.00
Net Short Term Debt Issuance
-1.75
-117.19%
10.17
0.00
Net Common Stock Issuance
1.79
0.00
-100.00%
7.33
Proceeds From Stock Option Exercised
0.53
0.00
-100.00%
0.01
Net Other Financing Charges
0.01
-56.59%
0.02
+106.74%
-0.25
Changes In Cash
-1.53
+75.13%
-6.15
-197.72%
6.29
Effect Of Exchange Rate Changes
-0.23
-801.17%
0.03
+150.70%
-0.07
Beginning Cash Position
2.18
-73.73%
8.29
+301.08%
2.07
End Cash Position
0.42
-80.89%
2.18
-73.73%
8.29
Free Cash Flow
-2.29
+62.26%
-6.07
-374.28%
-1.28
Interest Paid Supplemental Data
0.43
-71.25%
1.50
+936.52%
0.14
Income Tax Paid Supplemental Data
0.00
0.00
0.00
Change In Interest Payable
-0.06
-157.29%
0.10
+1024.27%
0.01
Common Stock Issuance
1.79
0.00
-100.00%
7.33
Issuance Of Capital Stock
1.79
0.00
-100.00%
7.33
Sale Of Business
0.00
-100.00%
0.06
-98.46%
3.74
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category